Kalkanis James G, Whitworth Craig, Rybak Leonard P
Department of Surgery, Southern Illinois University School of Medicine, Springfield, Illinois 62794-19653, USA.
Laryngoscope. 2004 Mar;114(3):538-42. doi: 10.1097/00005537-200403000-00028.
OBJECTIVES/HYPOTHESIS: Cisplatin ototoxicity is a major dose-limiting factor in the treatment of several neoplasms. Vitamin E, a slow-acting free radical scavenger, has been shown to ameliorate nephrotoxicity and endothelial cell damage in animals receiving cisplatin. The purpose of the study was to determine the effectiveness of vitamin E as an otoprotectant.
Prospective, randomized controlled trial in the rat model.
Wistar rats (weight, 261-386 g) were sedated using 172.4 mg/kg intramuscular ketamine and 3.4 mg/kg xylazine. Baseline auditory brainstem response (ABR) testing was performed in response to clicks and 8-, 16-, and 32-kHz tone bursts. After auditory thresholds were determined, the animals received intraperitoneal drug administration according to one of three group classifications. Group 1 received 4 g/kg vitamin E followed after 30 minutes by 16 mg/kg cisplatin. Group 2 received 6 mL/kg soybean oil followed after 30 minutes by cisplatin. Group 3 received soybean oil followed after 30 minutes by 16 mL/kg saline. After 3 days' follow-up, ABR testing was performed and threshold changes were recorded. Cochleae were removed and processed for scanning electron microscopy after follow-up auditory testing was carried out.
Group 2 animals showed marked hearing loss with average threshold shifts of 28.75 +/- 2.3 dB for clicks, 30.0 +/- 1.9 dB at 8 kHz, 21.25 +/- 4.0 dB at 16 kHz, and 45.0 +/- 4.2 dB at 32 kHz. No significant loss was observed in group 3 with shifts of 2 +/- 1.3 dB, 3 +/-3.0 dB, -2.2 +/- 3.1 dB, and -1.1 +/- 4.0 dB for clicks and tone bursts at 8, 16, and 32 kHz, respectively. Significant protection was seen in group 1 animals compared with group 2 animals. In the former group, threshold shifts of 12.5 +/- 3.1 dB for clicks, 7.5 +/- 2.5 dB at 8 kHz, 5.0 +/- 3.3 dB at 16 kHz, and 24.4 +/- 5.6 dB at 32 kHz were observed. These findings were supported by the scanning electron microscope observations that severe outer hair cell destruction occurred in group 2 rats, whereas outer hair cells were preserved to a much greater extent in the cochleae of rats in group 1 that were pretreated with vitamin E.
Vitamin E appears to have a protective effect against cisplatin ototoxicity.
目的/假设:顺铂耳毒性是多种肿瘤治疗中的主要剂量限制因素。维生素E是一种起效缓慢的自由基清除剂,已被证明可改善接受顺铂治疗的动物的肾毒性和内皮细胞损伤。本研究的目的是确定维生素E作为耳保护剂的有效性。
大鼠模型中的前瞻性随机对照试验。
使用172.4mg/kg肌肉注射氯胺酮和3.4mg/kg甲苯噻嗪对Wistar大鼠(体重261 - 386g)进行麻醉。进行基线听性脑干反应(ABR)测试,以检测对短声以及8kHz、16kHz和32kHz纯音刺激的反应。确定听觉阈值后,根据三种分组之一对动物进行腹腔内给药。第1组接受4g/kg维生素E,30分钟后再接受16mg/kg顺铂。第2组接受6mL/kg大豆油,30分钟后再接受顺铂。第3组接受大豆油,30分钟后再接受16mL/kg生理盐水。随访3天后,进行ABR测试并记录阈值变化。随访听觉测试后,取出耳蜗并进行扫描电子显微镜检查。
第2组动物出现明显听力损失,短声平均阈值偏移为28.75±2.3dB,8kHz为30.0±1.9dB,16kHz为21.25±4.0dB,32kHz为45.0±4.2dB。第3组未观察到明显损失,短声以及8kHz、16kHz和32kHz纯音刺激的阈值偏移分别为2±1.3dB、3±3.0dB、 - 2.2±3.1dB和 - 1.1±4.0dB。与第2组动物相比,第1组动物有明显的保护作用。在第1组中,短声阈值偏移为12.5±3.1dB,8kHz为7.5±2.5dB,16kHz为5.0±3.3dB,32kHz为24.4±5.6dB。扫描电子显微镜观察结果支持了这些发现,即第2组大鼠的外毛细胞发生严重破坏,而在预先用维生素E处理的第1组大鼠的耳蜗中,外毛细胞得到了更大程度的保留。
维生素E似乎对顺铂耳毒性具有保护作用。